HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
NYSE:HIMS • US4330001060
15.46 USD
-0.05 (-0.32%)
At close: Feb 24, 2026
15.55 USD
+0.09 (+0.58%)
Pre-Market: 2/25/2026, 7:49:50 AM
HIMS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. HIMS has a medium profitability rating, but doesn't score so well on its financial health evaluation. HIMS does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- In the past year HIMS was profitable.
- HIMS had a positive operating cash flow in the past year.
- In the past 5 years HIMS reported 4 times negative net income.
- The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
1.2 Ratios
- HIMS's Return On Assets of 5.99% is amongst the best of the industry. HIMS outperforms 82.18% of its industry peers.
- The Return On Equity of HIMS (23.03%) is better than 90.10% of its industry peers.
- HIMS's Return On Invested Capital of 5.84% is fine compared to the rest of the industry. HIMS outperforms 62.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROIC | 5.84% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- HIMS has a Profit Margin of 6.05%. This is amongst the best in the industry. HIMS outperforms 82.18% of its industry peers.
- HIMS's Operating Margin of 5.96% is fine compared to the rest of the industry. HIMS outperforms 67.33% of its industry peers.
- With an excellent Gross Margin value of 75.01%, HIMS belongs to the best of the industry, outperforming 90.10% of the companies in the same industry.
- In the last couple of years the Gross Margin of HIMS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- HIMS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 2.59 indicates that HIMS is not a great score, but indicates only limited risk for bankruptcy at the moment.
- With a Altman-Z score value of 2.59, HIMS perfoms like the industry average, outperforming 57.43% of the companies in the same industry.
- The Debt to FCF ratio of HIMS is 8.13, which is on the high side as it means it would take HIMS, 8.13 years of fcf income to pay off all of its debts.
- HIMS's Debt to FCF ratio of 8.13 is in line compared to the rest of the industry. HIMS outperforms 50.49% of its industry peers.
- A Debt/Equity ratio of 1.67 is on the high side and indicates that HIMS has dependencies on debt financing.
- HIMS has a Debt to Equity ratio of 1.67. This is in the lower half of the industry: HIMS underperforms 69.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Altman-Z | 2.59 |
ROIC/WACC0.67
WACC8.67%
2.3 Liquidity
- A Current Ratio of 1.88 indicates that HIMS should not have too much problems paying its short term obligations.
- HIMS's Current ratio of 1.88 is fine compared to the rest of the industry. HIMS outperforms 78.22% of its industry peers.
- HIMS has a Quick Ratio of 1.64. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.64, HIMS is in the better half of the industry, outperforming 67.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 |
3. Growth
3.1 Past
- HIMS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.41%.
EPS 1Y (TTM)-7.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.41%
3.2 Future
- The Earnings Per Share is expected to grow by 51.33% on average over the next years. This is a very strong growth
- Based on estimates for the next years, HIMS will show a quite strong growth in Revenue. The Revenue will grow by 12.27% on average per year.
EPS Next Y16.28%
EPS Next 2Y26.07%
EPS Next 3Y68.86%
EPS Next 5Y51.33%
Revenue Next Year16.69%
Revenue Next 2Y17.68%
Revenue Next 3Y13.77%
Revenue Next 5Y12.27%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 30.92, HIMS can be considered very expensive at the moment.
- The rest of the industry has a similar Price/Earnings ratio as HIMS.
- HIMS's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.98.
- With a Price/Forward Earnings ratio of 26.59, HIMS can be considered very expensive at the moment.
- The rest of the industry has a similar Price/Forward Earnings ratio as HIMS.
- When comparing the Price/Forward Earnings ratio of HIMS to the average of the S&P500 Index (28.01), we can say HIMS is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.92 | ||
| Fwd PE | 26.59 |
4.2 Price Multiples
- HIMS's Enterprise Value to EBITDA is on the same level as the industry average.
- The rest of the industry has a similar Price/Free Cash Flow ratio as HIMS.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.46 | ||
| EV/EBITDA | 20.52 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HIMS does not grow enough to justify the current Price/Earnings ratio.
- HIMS has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as HIMS's earnings are expected to grow with 68.86% in the coming years.
PEG (NY)1.9
PEG (5Y)N/A
EPS Next 2Y26.07%
EPS Next 3Y68.86%
5. Dividend
5.1 Amount
- HIMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
15.46
-0.05 (-0.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-23 2026-02-23/amc
Earnings (Next)05-04 2026-05-04
Inst Owners94.2%
Inst Owner Change-9.84%
Ins Owners5.93%
Ins Owner Change-1.34%
Market Cap3.52B
Revenue(TTM)N/A
Net Income(TTM)133.79M
Analysts67.27
Price Target30 (94.05%)
Short Float %37.45%
Short Ratio3.62
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)-2.29%
PT rev (3m)-11.57%
EPS NQ rev (1m)15.33%
EPS NQ rev (3m)-32.54%
EPS NY rev (1m)0.73%
EPS NY rev (3m)-20.78%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.92 | ||
| Fwd PE | 26.59 | ||
| P/S | 1.59 | ||
| P/FCF | 29.46 | ||
| P/OCF | 10.83 | ||
| P/B | 6.06 | ||
| P/tB | 27.75 | ||
| EV/EBITDA | 20.52 |
EPS(TTM)0.5
EY3.23%
EPS(NY)0.58
Fwd EY3.76%
FCF(TTM)0.52
FCFY3.39%
OCF(TTM)1.43
OCFY9.24%
SpS9.71
BVpS2.55
TBVpS0.56
PEG (NY)1.9
PEG (5Y)N/A
Graham Number5.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROCE | 7.39% | ||
| ROIC | 5.84% | ||
| ROICexc | 9.03% | ||
| ROICexgc | 14.91% | ||
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% | ||
| FCFM | 5.4% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Debt/EBITDA | 5.57 | ||
| Cap/Depr | 484.08% | ||
| Cap/Sales | 9.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 186.53% | ||
| Profit Quality | 89.31% | ||
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 | ||
| Altman-Z | 2.59 |
F-Score3
WACC8.67%
ROIC/WACC0.67
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.36%
EPS Next Y16.28%
EPS Next 2Y26.07%
EPS Next 3Y68.86%
EPS Next 5Y51.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.41%
Revenue Next Year16.69%
Revenue Next 2Y17.68%
Revenue Next 3Y13.77%
Revenue Next 5Y12.27%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year350.34%
EBIT Next 3Y88.26%
EBIT Next 5Y57.83%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to HIMS.
What is the valuation status of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a valuation rating of 3 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the financial health of HIMS & HERS HEALTH INC (HIMS) stock?
The financial health rating of HIMS & HERS HEALTH INC (HIMS) is 3 / 10.